Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:MBOT NYSE:MLSS NASDAQ:SNWV NASDAQ:TMCI On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMBOTMicrobot Medical$2.11-3.9%$2.39$1.60▼$4.67$140.70M1.061.81 million shs757,777 shsMLSSMilestone Scientific$0.37-7.0%$0.30$0.22▼$1.05$29.93M0.971.53 million shs309,328 shsSNWVSanuwave Health$16.09+0.6%$19.33$15.35▼$46.58$138.38M1.3771,700 shs42,782 shsTMCITreace Medical Concepts$2.19+12.6%$1.62$1.17▼$7.78$140.26M1.1769,109 shs376,987 shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMBOTMicrobot Medical+2.82%+4.29%-15.44%+6.83%-13.10%MLSSMilestone Scientific-12.43%+18.40%+45.47%+55.72%-57.87%SNWVSanuwave Health+2.76%+1.72%-4.99%-37.98%-46.84%TMCITreace Medical Concepts-3.48%+4.30%+7.18%-7.18%-71.60%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeMBOTMicrobot Medical$2.11-3.9%$2.39$1.60▼$4.67$140.70M1.061.81 million shs757,777 shsMLSSMilestone Scientific$0.37-7.0%$0.30$0.22▼$1.05$29.93M0.971.53 million shs309,328 shsSNWVSanuwave Health$16.09+0.6%$19.33$15.35▼$46.58$138.38M1.3771,700 shs42,782 shsTMCITreace Medical Concepts$2.19+12.6%$1.62$1.17▼$7.78$140.26M1.1769,109 shs376,987 shsThe 7 Hottest IPOs On Wall Street’s 2026 WatchlistMarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceMBOTMicrobot Medical+2.82%+4.29%-15.44%+6.83%-13.10%MLSSMilestone Scientific-12.43%+18.40%+45.47%+55.72%-57.87%SNWVSanuwave Health+2.76%+1.72%-4.99%-37.98%-46.84%TMCITreace Medical Concepts-3.48%+4.30%+7.18%-7.18%-71.60%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceMBOTMicrobot Medical 2.60Moderate Buy$7.50258.00% UpsideMLSSMilestone Scientific 3.00Buy$1.00166.67% UpsideSNWVSanuwave Health 2.50Moderate Buy$51.00221.16% UpsideTMCITreace Medical Concepts 1.86Reduce$4.77114.38% UpsideCurrent Analyst Ratings BreakdownLatest MLSS, MBOT, SNWV, and TMCI Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/20/2026TMCITreace Medical Concepts Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/14/2026MBOTMicrobot Medical HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$12.004/10/2026MBOTMicrobot Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)3/30/2026SNWVSanuwave Health Zacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeHold ➝ Strong Sell3/30/2026SNWVSanuwave Health Roth MkmSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$53.00 ➝ $47.003/27/2026SNWVSanuwave Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (D-) ➝ Hold (C-)3/2/2026TMCITreace Medical Concepts Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$7.50 ➝ $7.00(Data available from 5/12/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookMBOTMicrobot MedicalN/AN/AN/AN/A$1.15 per shareN/AMLSSMilestone Scientific$8.97M3.36N/AN/A$0.11 per share3.41SNWVSanuwave Health$44.05M3.10$1.73 per share9.17$0.19 per share83.58TMCITreace Medical Concepts$207.32M0.70N/AN/A$1.37 per share1.62Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateMBOTMicrobot Medical-$13.14M-$0.29N/AN/AN/AN/A-24.44%-23.12%5/13/2026 (Estimated)MLSSMilestone Scientific-$6.93M-$0.06N/AN/AN/A-52.01%-60.26%-40.23%N/ASNWVSanuwave Health$11.81M-$0.16N/A16.72N/A26.64%-141.56%34.53%5/12/2026 (Estimated)TMCITreace Medical Concepts-$59M-$0.97N/AN/AN/A-29.44%-64.43%-29.76%N/ALatest MLSS, MBOT, SNWV, and TMCI EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2026N/AMBOTMicrobot Medical-$0.08N/AN/AN/A$0.45 millionN/A5/12/2026Q1 2026SNWVSanuwave Health-$0.14N/AN/AN/A$9.60 millionN/A5/8/2026Q1 2026TMCITreace Medical Concepts-$0.31-$0.28+$0.03-$0.28$45.96 million$47.20 million3/27/2026Q4 2025MBOTMicrobot Medical-$0.06-$0.04+$0.02-$0.04$0.11 millionN/A3/26/2026Q4 2025SNWVSanuwave Health$0.17$0.03-$0.14$0.6360$13.23 million$13.09 million2/27/2026Q4 2025TMCITreace Medical Concepts-$0.15-$0.15N/A-$0.15$61.76 million$62.52 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthMBOTMicrobot MedicalN/AN/AN/AN/AN/AMLSSMilestone ScientificN/AN/AN/AN/AN/ASNWVSanuwave HealthN/AN/AN/AN/AN/ATMCITreace Medical ConceptsN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioMBOTMicrobot MedicalN/A23.3323.16MLSSMilestone ScientificN/A2.851.86SNWVSanuwave Health10.081.381.05TMCITreace Medical Concepts0.644.313.13Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipMBOTMicrobot Medical16.30%MLSSMilestone Scientific5.79%SNWVSanuwave Health42.53%TMCITreace Medical Concepts84.08%Insider OwnershipCompanyInsider OwnershipMBOTMicrobot Medical4.74%MLSSMilestone Scientific12.51%SNWVSanuwave Health14.40%TMCITreace Medical Concepts23.42%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableMBOTMicrobot Medical2067.16 million63.98 millionOptionableMLSSMilestone Scientific3080.45 million58.61 millionOptionableSNWVSanuwave Health408.60 million7.36 millionN/ATMCITreace Medical Concepts25064.78 million49.61 millionOptionableMLSS, MBOT, SNWV, and TMCI HeadlinesRecent News About These CompaniesTreace Medical Concepts, Inc. Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses3 hours ago | globenewswire.comTreace Medical Concepts Inc (TMCI) Q1 2026 Earnings Call Highlights: Navigating Revenue ...May 9 at 2:40 PM | finance.yahoo.comTreace Medical Concepts Q1 Earnings Call HighlightsMay 8, 2026 | marketbeat.comTreace Medical Concepts (NASDAQ:TMCI) Issues Quarterly Earnings ResultsMay 8, 2026 | marketbeat.comTreace Medical Concepts: Q1 Earnings SnapshotMay 8, 2026 | myjournalcourier.comMTreace Medical Concepts (TMCI) Reports Q1 Loss, Beats Revenue EstimatesMay 8, 2026 | zacks.comTreace Medical Concepts Reports First Quarter 2026 Financial ResultsMay 8, 2026 | globenewswire.comTreace Medical Concepts Inc (TMCI) Q1 2026 Earnings Report Preview: What To ExpectMay 7, 2026 | finance.yahoo.comLucid Diagnostics (NASDAQ:LUCD) & Treace Medical Concepts (NASDAQ:TMCI) Financial SurveyMay 4, 2026 | americanbankingnews.comHow The Treace Medical Concepts (TMCI) Story Is Shifting With Mixed Analyst ExpectationsMay 3, 2026 | finance.yahoo.comTreace Medical Concepts, Inc. (NASDAQ:TMCI) Receives Consensus Recommendation of "Reduce" from AnalystsMay 3, 2026 | marketbeat.comTreace Medical Concepts (TMCI) to Release Quarterly Earnings on FridayMay 1, 2026 | americanbankingnews.comTreace Medical Concepts (TMCI) to Release Earnings on FridayMay 1, 2026 | marketbeat.comWeber Capital Management LLC ADV Invests $1.45 Million in Treace Medical Concepts, Inc. $TMCIApril 27, 2026 | marketbeat.comTreace Medical Concepts (NASDAQ:TMCI) Upgraded to Sell at Wall Street ZenApril 27, 2026 | marketbeat.comTreace Medical Concepts, Inc. to Release First Quarter 2026 Financial Results and Host Conference CallApril 24, 2026 | quiverquant.comQTreace to Report First Quarter 2026 Financial Results on May 8, 2026April 24, 2026 | globenewswire.comWall Street Zen Downgrades Treace Medical Concepts (NASDAQ:TMCI) to Strong SellApril 19, 2026 | marketbeat.comHow The Treace Medical Concepts (TMCI) Narrative Is Shifting With New Targets And Product PlansApril 18, 2026 | finance.yahoo.comTreace Medical Concepts Announces Leadership Transition and OutlookApril 11, 2026 | theglobeandmail.comTreace Medical Concepts (TMCI) price target increased by 12.28% to 4.08April 10, 2026 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMLSS, MBOT, SNWV, and TMCI Company DescriptionsMicrobot Medical NASDAQ:MBOT$2.10 -0.09 (-3.88%) As of 11:54 AM Eastern This is a fair market value price provided by Massive. Learn more.Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.Milestone Scientific NYSE:MLSS$0.37 -0.03 (-7.05%) As of 11:53 AM Eastern This is a fair market value price provided by Massive. Learn more.Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.Sanuwave Health NASDAQ:SNWV$16.09 +0.09 (+0.56%) As of 11:54 AM Eastern This is a fair market value price provided by Massive. Learn more.SANUWAVE Health, Inc., a shock wave technology company, researches, develops, and commercializes noninvasive, high-energy, and acoustic shock waves for regenerative medicine and other applications in the United States and internationally. Its shockwaves are used to produce a biological response resulting in the body healing itself through the repair and regeneration of tissue, and musculoskeletal and vascular structures. The company's lead regenerative product is the dermaPACE device for treating diabetic foot ulcers. Its portfolio of healthcare products and product candidates activate biologic signaling and angiogenic responses, including new vascularization and microcirculatory improvement, which helps to restore the body's normal healing processes and regeneration. The company also focuses on applying its Pulsed Acoustic Cellular Expression technology in wound healing, orthopedic, plastic/cosmetic, and cardiac conditions. In addition, it offers UltraMIST, non-contact and non-thermal ultrasound therapy device used to treat diabetic foot ulcers, pressure ulcers, venous leg ulcers, deep tissue pressure injuries, and surgical wounds; and orthoPACE system to treat tendinopathies and acute and nonunion fractures. The company was founded in 2005 and is headquartered in Suwanee, Georgia.Treace Medical Concepts NASDAQ:TMCI$2.18 +0.25 (+12.63%) As of 11:53 AM Eastern This is a fair market value price provided by Massive. Learn more.Treace Medical Concepts, Inc., a medical technology company, designs, manufactures, and markets medical devices in the United States. The company offers Lapiplasty 3D bunion correction system that combines instruments, implants, and surgical methods designed to surgically correct three planes of the bunion deformity. It also provides Lapiplasty mini-incision system designed to allow the Lapiplasty procedure to be performed through a 3.5cm incision. In addition, the company offers Adductoplasty system designed for reproducible realignment, stabilization, and fusion of the midfoot. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra, Florida. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Sony's $4 Billion Bet on Rock & Roll Royalties Ubiquiti’s Uptrend Can Continue, But Don’t Rush to Buy It AI Demand Fuels Strong Q1 Earnings for Constellation Energy TMC Forges a New EV Supply Chain at the Bottom of the Sea MercadoLibre Boldly Invests in Growth: Discount Deepens Manic Monday.com: The Rally Is Just the Beginning for this SaaS Leader 5 Stocks Positioned to Benefit From the AI Inference Boom Sell in May and Go Away—Starting With These 3 Stocks Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
